Previous Article | Next Article ![]()
Infection and Immunity, June 1999, p. 2862-2866, Vol. 67, No. 6
Veterans Affairs Medical
Center,1 Creighton University School of
Medicine,2 and University of
Nebraska College of Medicine,3 Omaha, Nebraska
Received 28 December 1998/Returned for modification 27 January
1999/Accepted 15 March 1999
We investigated the role of pneumolysin's complement-activating
activity during Streptococcus pneumoniae bacteremia in a
hypocomplementemic, cirrhotic host. Isogenic mutant pneumococcal
strains, in which pneumolysin was expressed from a plasmid, were used.
These strains included H+C+, expressing wild-type pneumolysin with both
cytolytic and complement-activating activity; PLY
0019-9567/99/$04.00+0
Role of Pneumolysin's Complement-Activating
Activity during Pneumococcal Bacteremia in Cirrhotic Rats
, carrying the
plasmid without the pneumolysin gene; and, H+C
, expressing
pneumolysin with cytolytic activity only. In control rats, intravenous
infection with 2.0 × 107 CFU of H+C+ per ml of blood
resulted in a decrease in bacteremia of 3.5 log units by 18 h
postinfection and 55% mortality. By contrast, cirrhotic rats infected
similarly with the H+C+ strain demonstrated a 0.2-log-unit increase in
bacteremia by 18 h postinfection and 100% mortality. Both control
and cirrhotic rats cleared the PLY
strain more effectively from their
bloodstreams by 18 h postinfection (6.2 and 5.6 log unit
decreases, respectively). Infection with the PLY
strain also resulted
in low mortality (0 and 14%, respectively) for control and cirrhotic
rats. When infected with the H+C
strain (without
complement-activating activity), both groups cleared the organism from
their bloodstreams nearly as well as they did the PLY
strain.
Furthermore, the mortality rate for control and cirrhotic rats was
identical after infection with the H+C
strain. These studies suggest
that pneumolysin production contributes to decreased pneumococcal
clearance from the bloodstream and higher mortality in both control and
cirrhotic rats. However, pneumolysin's complement-activating activity
may uniquely enhance pneumococcal virulence in the hypocomplementemic,
cirrhotic host.
*
Corresponding author. Mailing address: Research Service
(151), V.A. Medical Center, 4101 Woolworth Ave., Omaha, NE 68105. Phone: (402) 346-8800 ext. 3033. Fax: (402) 449-0604. E-mail: mgentry{at}creighton.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»